Nom du produit:1-(4-bromo-1-naphthyl)hexahydropyrimidine-2,4-dione

IUPAC Name:1-(4-bromonaphthalen-1-yl)-1,3-diazinane-2,4-dione

CAS:35071-12-6
Formule moléculaire:C14H11BrN2O2
Pureté:95%
Numéro de catalogue:CM1076089
Poids moléculaire:319.16

Unité d'emballage Stock disponible Prix($) Quantité
CM1076089-100mg in stock șƏƩ
CM1076089-250mg in stock ƩƻƏ
CM1076089-1g in stock ǕňƩň

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:35071-12-6
Formule moléculaire:C14H11BrN2O2
Point de fusion:-
Code SMILES:BrC1=CC=C(N2CCC(=O)NC2=O)C2=C1C=CC=C2
Densité:
Numéro de catalogue:CM1076089
Poids moléculaire:319.16
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Related Products